SCHEMBL10132270

SCHEMBL10132270

COc1cc2c(ccc3c4ccc5c(c4c[n+](C)c23)OCO5)c(-c2ccc(-c3ccccc3)cc2)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAD Q92934 7/20 0.51
ALDH1A1 P00352 6/20 0.51
MAPT P10636 6/20 0.51
HPGD P15428 6/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
MAPK1 P28482 5/20 0.51
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
LMNA P02545 4/20 0.51
ACHE P22303 4/20 0.51
KDM4E B2RXH2 4/20 0.51
BCHE P06276 3/20 0.51
TP53 P04637 3/20 0.51
CYP3A4 P08684 3/20 0.51
ALOX15 P16050 3/20 0.51
ALOX12 P18054 3/20 0.51
HSD17B10 Q99714 3/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
RGS17 Q9UGC6 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL423231 0.99 ALDH1A1 (0.52) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10132268 0.98 BAD (0.53) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10132265 0.91 ALDH1A1 (0.52) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10132288 0.85 BAD (0.51) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10132413 0.85 BAD (0.61) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL13283971 0.84 ALDH1A1 (0.40) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10132266 0.83 ALDH1A1 (0.51) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL13284349 0.82 RAC1 (0.53) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10132640 0.81 RAC1 (0.44) BADALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL10162982 0.80 RAC1 (0.55) BADALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH BAD 384/4885ALDH1A1 3095/4885MAPT 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.